How Renal Function and Comorbidities Affect Dosing for NOACs

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient's renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient’s renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.